查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1578936

单细胞试剂套件市场：按产品类型、技术和最终用户 - 2025-2030 年全球预测

Single Cell Kit Market by Product Type (Instruments, Reagents And Kits), Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年单细胞套件市值为15.4亿美元，预计2024年将达到17.3亿美元，复合年增长率为11.12%，到2030年将达到32.3亿美元。

单细胞套件市场的范围和定义包括为分析单一细胞而设计的工具和技术，提供对细胞功能、遗传物质和微环境的深入了解。对单细胞套件的需求主要是由精准医学、药物发现和先进基因组研究日益增长的需求所驱动的。这些套件的应用涵盖生物技术、製药和学术领域，最终用途为实验室、医院和诊断中心。主要市场影响包括生物技术的快速进步、研发资金的增加以及个人化医疗需求的快速成长。

主要市场统计
基准年[2023] 15.4亿美元
预测年份 [2024] 17.3亿美元
预测年份 [2030] 32.3亿美元
复合年增长率（%） 11.12%

将人工智慧和机器学习与单细胞分析相结合以得出预测分析，从而增强临床环境中的决策，并存在重大的成长机会。此外，将应用扩展到免疫学、癌症研究和发育生物学也是一个有前途的途径。微流体和具有成本效益的高通量测序的创新也至关重要，并且有可能使单细胞技术更容易获得和高效。

然而，这个市场并非没有挑战。单细胞分析的高成本和缺乏标准化可能会阻碍生长。与资料分析和解释相关的技术复杂性也对广泛采用构成了障碍。为了克服这些限制，建议投资开发强大的生物资讯工具并促进学术、临床和工业合作。

市场的特点是技术创新快、竞争激烈，需要不断改进和适应。因此，公司应优先研究和开发单细胞分析新方法，特别是那些解决可扩展性和准确性的方法。透过专注于新兴市场并专注于与主要相关人员合作进行技术整合，预计将实现显着成长。随着精准医学的不断发展，单细胞套件的重要性将会增加，从而推动进一步的研究和市场扩张机会。

市场动态：揭示快速发展的单细胞套件市场的关键市场洞察

单细胞套件市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 单细胞分析技术的进步正在推动对更精确的单细胞套件的需求。
    • 单细胞套件在癌症研究和个人化医疗中的广泛应用推动了市场成长
    • 增加政府和私人对单细胞基因组学研究的资助，以加速套件开发
    • 学术和研究机构越来越多地采用单细胞套件进行复杂的生物学研究
  • 市场限制因素
    • 围绕单细胞研究的监管和道德担忧减缓了市场成长
    • 缺乏标准化方案和程序会影响单细胞分析结果的可靠性
  • 市场机会
    • 对精准医疗和个人化医疗保健的需求不断增长将推动单细胞试剂套件市场
    • 增加对单细胞基因组学研究的投资加速了单细胞套件市场的成长
    • 单细胞分析的技术进步扩大了单细胞套件的使用与采用
  • 市场挑战
    • 资料管理和分析工具在处理、储存和解释资讯方面的复杂性
    • 单细胞实验方案和工作流程缺乏标准化

波特五力：驾驭单细胞试剂套件市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解单细胞套件市场的外部影响

外部宏观环境因素在塑造单细胞套件市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解单细胞套件市场的竞争状况

对单细胞套件市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵单细胞套件市场供应商绩效评估

FPNV定位矩阵是评估单细胞套件市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了单细胞套件市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对单细胞试剂套件市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 单细胞分析技术的进步增加了对更准确的单细胞套件的需求。
      • 扩大单细胞套件在癌症研究和个人化医疗的应用将推动市场成长
      • 增加政府和私人对单细胞基因组研究的资助将加速套件的开发
      • 学术研究实验室更采用单细胞套件进行复杂的生物研究
    • 抑制因素
      • 围绕单细胞研究的监管和道德担忧减缓了市场成长
      • 缺乏标准化的通讯协定和程序会影响单细胞分析结果的可靠性。
    • 机会
      • 对精准医疗和个人化医疗保健的需求不断增长推动单细胞套件市场
      • 增加单细胞基因组研究的投资推动单细胞套件市场
      • 单细胞分析的技术进步正在扩大单细胞套件的使用和采用。
    • 任务
      • 资料管理和分析工具在处理、储存和解释资讯方面的复杂性
      • 单细胞通讯协定和工作流程缺乏标准化
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章单细胞套件市场：依产品类型

  • 装置
    • 细胞计数器
    • 流式细胞仪
    • 显微镜
  • 试剂和套件
    • 放大套件
    • 细胞裂解套件
    • 文库製备试剂套件
    • 核酸萃取试剂套件

第七章单细胞试剂套件市场：依技术分类

  • 次世代定序（NGS）
    • EXOME定序
    • RNA定序
    • 单细胞DNA定序
    • 全基因组序列分析
  • 聚合酵素链锁反应(PCR)
    • 数位PCR
    • 即时PCR

第八章单细胞试剂套件市场：依最终用户分类

  • 学术研究所
    • 调查机构
    • 大学
  • 合约调查机构
    • 外包调查服务
  • 医院和诊断实验室
    • 临床诊断
    • 病理实验室
  • 製药和生物技术公司
    • 药物开发
    • 药物发现

第九章美洲单细胞套件市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太单细胞试剂套件市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲单细胞套件市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 10x Genomics
  • Abcam plc
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Berkeley Lights
  • Bio-Rad Laboratories, Inc.
  • Dolomite Bio
  • Fluidigm Corporation
  • Horizon Discovery
  • Illumina, Inc.
  • Miltenyi Biotec
  • Mission Bio
  • NanoString Technologies
  • Partek Incorporated
  • Promega Corporation
  • QIAGEN
  • Sphere Fluidics
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • WaferGen Biosystems
Product Code: MRR-2B5802CFEA3A

The Single Cell Kit Market was valued at USD 1.54 billion in 2023, expected to reach USD 1.73 billion in 2024, and is projected to grow at a CAGR of 11.12%, to USD 3.23 billion by 2030.

The scope and definition of the single-cell kit market involve tools and technologies designed for the analysis of individual cells, providing deep insights into cellular function, genetic material, and the microenvironment. The necessity for single-cell kits primarily stems from the growing need for precision medicine, drug discovery, and advanced genomic research, as they enable scientists to study cellular heterogeneity which is crucial for understanding complex biological systems and diseases like cancer. The application of these kits extends across biotechnology, pharmaceuticals, and academic sectors, with their end-use spanning research laboratories, hospitals, and diagnostic centers. The key market influences include the rapid advancements in biotechnology, increased funding for R&D, and the surging demand for personalized medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 1.54 billion
Estimated Year [2024] USD 1.73 billion
Forecast Year [2030] USD 3.23 billion
CAGR (%) 11.12%

Significant growth opportunities exist in integrating artificial intelligence and machine learning with single-cell analysis to derive predictive analytics, thereby enhancing decision-making in clinical settings. Additionally, expanding applications in immunology, cancer research, and developmental biology represent promising avenues. Innovations in microfluidics and cost-effective, high-throughput sequencing are also pivotal, offering potential to make single-cell technologies more accessible and efficient.

However, the market is not without challenges. High costs associated with single-cell analysis and a lack of standardization could hinder growth. Technical complexities involved in data analysis and interpretation also present barriers to widespread adoption. To overcome these limitations, investments in developing robust bioinformatics tools and fostering collaborations among academic, clinical, and industrial entities are recommended.

The market is characterized by a blend of rapid innovation and high competition, demanding continuous improvement and adaptation. Therefore, businesses should prioritize R&D in new methodologies for single-cell analysis, particularly those addressing scalability and accuracy. Emphasizing alliances with key stakeholders for technology integration and focusing on emerging markets could drive substantial growth. As precision medicine continues to advance, the importance of single-cell kits is poised to grow, driving further research and market expansion opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single Cell Kit Market

The Single Cell Kit Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing advancements in single cell analysis technologies driving demand for more precise single cell kits
    • Growing application of single cell kits in cancer research and personalized medicine boosting market growth
    • Rising government and private funding for single-cell genomics research enhancing kit development
    • Escalating adoption of single cell kits in academic and research institutions for complex biological studies
  • Market Restraints
    • Regulations and ethical concerns surrounding single cell research delay market growth
    • Lack of standardized protocols and procedures impacts the reliability of single cell analysis results
  • Market Opportunities
    • Increasing demand for precision medicine and personalized healthcare is boosting the single cell kit market
    • Rising investment in single-cell genomics research is accelerating the growth of the single cell kit market
    • Technological advancements in single-cell analysis are expanding the applications and adoption of single cell kits
  • Market Challenges
    • Complexity in data management and analysis tools in handling, storing, and interpreting information
    • Lack of standardization in single-cell protocols and workflows

Porter's Five Forces: A Strategic Tool for Navigating the Single Cell Kit Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single Cell Kit Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single Cell Kit Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single Cell Kit Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single Cell Kit Market

A detailed market share analysis in the Single Cell Kit Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single Cell Kit Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single Cell Kit Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single Cell Kit Market

A strategic analysis of the Single Cell Kit Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single Cell Kit Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Abcam plc, Agilent Technologies, Becton, Dickinson and Company, Berkeley Lights, Bio-Rad Laboratories, Inc., Dolomite Bio, Fluidigm Corporation, Horizon Discovery, Illumina, Inc., Miltenyi Biotec, Mission Bio, NanoString Technologies, Partek Incorporated, Promega Corporation, QIAGEN, Sphere Fluidics, Takara Bio Inc., Thermo Fisher Scientific Inc., and WaferGen Biosystems.

Market Segmentation & Coverage

This research report categorizes the Single Cell Kit Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Instruments and Reagents And Kits. The Instruments is further studied across Cell Counters, Flow Cytometers, and Microscopes. The Reagents And Kits is further studied across Amplification Kits, Cell Lysis Kits, Library Preparation Kits, and Nucleic Acid Extraction Kits.
  • Based on Technology, market is studied across Next Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR). The Next Generation Sequencing (NGS) is further studied across Exome Sequencing, RNA Sequencing, Single Cell DNA Sequencing, and Whole Genome Sequencing. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
  • Based on End User, market is studied across Academic And Research Institutions, Contract Research Organizations, Hospitals And Diagnostic Laboratories, and Pharmaceutical And Biotechnology Companies. The Academic And Research Institutions is further studied across Research Organizations and Universities. The Contract Research Organizations is further studied across Outsourced Research Services. The Hospitals And Diagnostic Laboratories is further studied across Clinical Diagnostics and Pathology Labs. The Pharmaceutical And Biotechnology Companies is further studied across Drug Development and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing advancements in single cell analysis technologies driving demand for more precise single cell kits
      • 5.1.1.2. Growing application of single cell kits in cancer research and personalized medicine boosting market growth
      • 5.1.1.3. Rising government and private funding for single-cell genomics research enhancing kit development
      • 5.1.1.4. Escalating adoption of single cell kits in academic and research institutions for complex biological studies
    • 5.1.2. Restraints
      • 5.1.2.1. Regulations and ethical concerns surrounding single cell research delay market growth
      • 5.1.2.2. Lack of standardized protocols and procedures impacts the reliability of single cell analysis results
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for precision medicine and personalized healthcare is boosting the single cell kit market
      • 5.1.3.2. Rising investment in single-cell genomics research is accelerating the growth of the single cell kit market
      • 5.1.3.3. Technological advancements in single-cell analysis are expanding the applications and adoption of single cell kits
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in data management and analysis tools in handling, storing, and interpreting information
      • 5.1.4.2. Lack of standardization in single-cell protocols and workflows
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Single Cell Kit Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Cell Counters
    • 6.2.2. Flow Cytometers
    • 6.2.3. Microscopes
  • 6.3. Reagents And Kits
    • 6.3.1. Amplification Kits
    • 6.3.2. Cell Lysis Kits
    • 6.3.3. Library Preparation Kits
    • 6.3.4. Nucleic Acid Extraction Kits

7. Single Cell Kit Market, by Technology

  • 7.1. Introduction
  • 7.2. Next Generation Sequencing (NGS)
    • 7.2.1. Exome Sequencing
    • 7.2.2. RNA Sequencing
    • 7.2.3. Single Cell DNA Sequencing
    • 7.2.4. Whole Genome Sequencing
  • 7.3. Polymerase Chain Reaction (PCR)
    • 7.3.1. Digital PCR
    • 7.3.2. Real-Time PCR

8. Single Cell Kit Market, by End User

  • 8.1. Introduction
  • 8.2. Academic And Research Institutions
    • 8.2.1. Research Organizations
    • 8.2.2. Universities
  • 8.3. Contract Research Organizations
    • 8.3.1. Outsourced Research Services
  • 8.4. Hospitals And Diagnostic Laboratories
    • 8.4.1. Clinical Diagnostics
    • 8.4.2. Pathology Labs
  • 8.5. Pharmaceutical And Biotechnology Companies
    • 8.5.1. Drug Development
    • 8.5.2. Drug Discovery

9. Americas Single Cell Kit Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Single Cell Kit Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Single Cell Kit Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Abcam plc
  • 3. Agilent Technologies
  • 4. Becton, Dickinson and Company
  • 5. Berkeley Lights
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Dolomite Bio
  • 8. Fluidigm Corporation
  • 9. Horizon Discovery
  • 10. Illumina, Inc.
  • 11. Miltenyi Biotec
  • 12. Mission Bio
  • 13. NanoString Technologies
  • 14. Partek Incorporated
  • 15. Promega Corporation
  • 16. QIAGEN
  • 17. Sphere Fluidics
  • 18. Takara Bio Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. WaferGen Biosystems

LIST OF FIGURES

  • FIGURE 1. SINGLE CELL KIT MARKET RESEARCH PROCESS
  • FIGURE 2. SINGLE CELL KIT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SINGLE CELL KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SINGLE CELL KIT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SINGLE CELL KIT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SINGLE CELL KIT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SINGLE CELL KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SINGLE CELL KIT MARKET DYNAMICS
  • TABLE 7. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL KIT MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL KIT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL KIT MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CELL LYSIS KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL KIT MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL KIT MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL KIT MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL KIT MARKET SIZE, BY SINGLE CELL DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL KIT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL KIT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL KIT MARKET SIZE, BY OUTSOURCED RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 85. CANADA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 86. CANADA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 142. CHINA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 143. CHINA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 153. INDIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 154. INDIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)

TA